NCT02130973View on ClinicalTrials.gov

The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab

PHASE4UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Osteoporosis
Interventions
DRUG

Standard Clinical Practice Regimen

Standard Clinical Practice Regimen

DRUG

Experimental Cyclic Regimen

Experimental Cyclic Regimen

Trial Locations (1)

10993

Helen Hayes Hospital, West Haverstraw

Sponsors
All Listed Sponsors
lead

Health Research, Inc.

OTHER

NCT02130973 - The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab | Biotech Hunter | Biotech Hunter